Current review of the SarQoL®: a health-related quality of life questionnaire specific to sarcopenia
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“To this end, the SarQoL tool is a self-administered questionnaire for people with sarcopenia.[16, 122–124]”
From Sarcopenia: revised European consensus on definition and diagnosis (2019) · cites this paper as [123]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
Chen, L.-K., Liu, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Bahyah, K. S., Chou, M.-Y., Chen, L.-Y., Hsu, P.-S., Krairit, O., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.11.025 · Cited by 4,051
Fielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.01.003 · Cited by 3,256 · cited 3×
“Among the six definitions used, two were based on low lean mass alone (Baumgartner [37], Delmonico [52]) and four required both low muscle mass and decreased performance on a functional test (Cruz-Jentoft [3], Studenski [5], Fielding [4], Morley [6]).”
MethodInfluentialStudenski, S. A., Peters, K. W., Alley, D. E., Cawthon, P. M., McLean, R. R., Harris, T. B., Ferrucci, L., Guralnik, J. M., Fragala, M. S., Kenny, A. M., et al. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu010 · Cited by 2,545 · cited 3×
“Among the six definitions used, two were based on low lean mass alone (Baumgartner [37], Delmonico [52]) and four required both low muscle mass and decreased performance on a functional test (Cruz-Jentoft [3], Studenski [5], Fielding [4], Morley [6]).”
MethodInfluentialSarcopenia: origins and clinical relevance
Rosenberg, I. H. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.5.990s · Cited by 2,399 · cited 1×
“Beyond a certain defined threshold, this age-related phenomenon is considered abnormal; it was first defined by Rosenberg [2] in 1989 using the term ‘sarcopenia’.”
BackgroundCruz-Jentoft, A. J., Landi, F., Schneider, S. M., Zuniga, C., Arai, H., Boirie, Y., Chen, L.-K., Fielding, R. A., Martin, F. C., Michel, J.-P., et al. (2014) · Age and Ageing · doi:10.1093/ageing/afu115 · Cited by 1,963
Muscaritoli, M., Anker, S. D., Argilés, J., Aversa, Z., Bauer, J. M., Biolo, G., Boirie, Y., Bosaeus, I., Cederholm, T., Costelli, P., et al. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2009.12.004 · Cited by 1,732
SARC-F: A simple questionnaire to rapidly diagnose sarcopenia
Malmstrom, T. K., & Morley, J. E. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.05.018 · Cited by 1,319 · cited 3×
“Reference Sarcopenia diagnostic criteria QoL tool(s) used Results Beaudart [27] EWGSOP [3] SF-36 EQ-5D EQ-VAS Poorer QoL of sarcopenic patients only for physical functioning No difference in QoL between groups No difference in QoL between groups Go [28] ALM/ht2 <2SD of the sex-specific means of young adults EQ-5D Lowe…”
BackgroundInfluentialSarcopenia with limited mobility: an international consensus
Morley, J. E., Abbatecola, A. M., Argiles, J. M., Baracos, V., Bauer, J., Bhasin, S., Cederholm, T., Stewart Coats, A. J., Cummings, S. R., Evans, W. J., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.04.014 · Cited by 1,125
Shafiee, G., Keshtkar, A., Soltani, A., Ahadi, Z., Larijani, B., & Heshmat, R. (2017) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-017-0302-x · Cited by 1,076 · cited 1×
“community-dwelling subjects aged 65 years or older [11,12], is prospectively associated with several adverse outcomes,”
BackgroundPrevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women
Iannuzzi-Sucich, M., Prestwood, K. M., & Kenny, A. M. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.12.m772 · Cited by 890 · cited 1×
“[25] published data showing a significant correlation between low muscle mass and reduced QoL but only for the general health score of the SF-36 questionnaire and only for men, not for women.”
Background
Research works printed but not linked: 33
- 10.1093/ageing/afq034 · DOI · Paper page
- 10.1007/s00198-012-1913-1 · DOI · Paper page
- 10.1371/journal.pone.0169548 · DOI · Paper page
- 10.1186/2049-3258-72-45 · DOI · Paper page
- 10.1097/00005650-199206000-00002 · DOI · Paper page
- 10.3109/07853890109002087 · DOI · Paper page
- 10.1016/0168-8510(96)00822-6 · DOI · Paper page
- 10.1093/ageing/afl024 · DOI · Paper page
- 10.1007/s11357-014-9714-4 · DOI
- 10.1007/s40520-017-0775-y · DOI
- 10.1016/j.ijcard.2016.07.135 · DOI · Paper page
- 10.1007/s11136-013-0388-7 · DOI
- 10.1016/j.exger.2015.05.003 · DOI · Paper page
- 10.4082/kjfm.2013.34.4.281 · DOI
- 10.1371/journal.pone.0110448 · DOI
- 10.1016/j.jamda.2017.04.005 · DOI
- 10.1007/s00520-012-1460-5 · DOI
- 10.1093/ageing/afs197 · DOI · Paper page
- 10.1111/j.1467-789X.2011.00878.x · DOI · Paper page
- 10.1093/oxfordjournals.aje.a009520 · DOI · Paper page
- 10.1016/j.jamda.2016.07.029 · DOI
- 10.1111/ctr.12493 · DOI · Paper page
- 10.1093/ageing/afv133 · DOI · Paper page
- Beaudart C, J Cachexia Sarcopenia Muscle
- Johnson C, 2011, Eur Organ Res Treat Cancer
- Guyatt GH, 1986, Cmaj, 15, 889
- Beaudart C, 2016, Age Ageing, 0, 1
- 10.1186/1471-2458-14-676 · DOI
- 10.1186/1471-2458-14-660 · DOI
- 10.1002/jcsm.12021 · DOI · Paper page
- 10.1007/s00198-013-2376-8 · DOI · Paper page
- Beaudart C, 2014, J Musculoskelet Neuronal Interact, 14, 425
- Beaudart C, 2014, Exp Gerontol, 61, 31, 10.1016/j.exger.2014.11.014 · DOI
Cited by
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Self-citationTsekoura, M., Billis, E., Tsepis, E., Dimitriadis, Z., Matzaroglou, C., Tyllianakis, M., Panagiotopoulos, E., & Gliatis, J. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7120480 · Cited by 142
“Evaluating the impact of sarcopenia on individuals’ QoL with a disease-specific tool is important for detecting treatment effectiveness and for observing longitudinal health changes amongst this population [54,55].”
Background
Metadata
- Authors
- Beaudart, C., Reginster, J.-Y., Geerinck, A., Locquet, M., & Bruyère, O.
- Affiliations
- Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium
- Venue
- Expert Review of Pharmacoeconomics & Outcomes Research
- Publisher
- Informa UK Limited
- Published
- 2017-07-04
- Volume
- 17
- Issue
- 4
- Pages
- 335-341
- ISSN
- 1473-7167
- 1744-8379
- Cited by
- 39
- References
- 19
- Language
- en
- Funders
- the FNRS
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Current review of the SarQoL®: a health-related quality of life questionnaire specific to sarcopenia. https://app.cochat.ai/papers/10.1080/14737167.2017.1360768
- The paper
- Beaudart, C., Reginster, J.-Y., Geerinck, A., Locquet, M., & Bruyère, O. (2017). Current review of the SarQoL®: a health-related quality of life questionnaire specific to sarcopenia. Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1080/14737167.2017.1360768
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.